Enhancing melanoma therapy with hydrogel microneedles

Area of Science:

• Biomaterials Science
• Nanotechnology
• Dermatology

Background:

• Melanoma presents a significant global health challenge, characterized by invasiveness and resistance to conventional treatments like chemotherapy and immunotherapy.
• Existing therapies often suffer from limited efficacy and substantial side effects due to systemic drug distribution.
• Microneedles (MNs) are emerging as a safe and effective drug delivery system, with hydrogel microneedles (HMNs) showing particular promise.

Purpose of the Study:

• To review recent advancements in hydrogel microneedles (HMNs) for melanoma therapy.
• To explore HMN applications in early diagnosis via biomarker extraction.
• To discuss the role of HMNs in multimodal treatment strategies and analyze current materials and fabrication techniques.

Main Methods:

• Review of recent literature on hydrogel microneedle technology for melanoma.
• Analysis of HMN applications in diagnosis and therapy.
• Discussion of matrix materials, fabrication methods, and limitations.

Main Results:

• HMNs enable direct drug delivery into the tumor microenvironment (TME), enhancing bioavailability and reducing systemic toxicity.
• HMNs show potential for biomarker extraction for early melanoma diagnosis.
• HMNs can support various treatment modalities including chemotherapy, immunotherapy, phototherapy, and combination therapies.

Conclusions:

• HMNs represent a promising platform for advanced melanoma treatment, offering improved drug delivery and therapeutic outcomes.
• Further research into HMN materials, fabrication, and clinical translation is warranted.
• HMNs have the potential to overcome limitations of conventional melanoma therapies.